3 Sep 17

Patients were identified in the Surveillance, Epidemiology, and End Results-Medicare database, which at the time contained information of patients identified as having cancer in areas that represented approximately 14 % of the U.S. Population. Outcomes demonstrated that more sufferers who received an ESA developed deep vein thrombosis or pulmonary embolism, in comparison with patients who didn’t. Overall survival was identical in both combined groups. The number of patients receiving ESAs increased approximately 10-fold from 1991 through 2002, with approximately 50 % of patients with advanced malignancy undergoing chemotherapy receiving ESAs by 2002. The rate of blood transfusion each year during the same time frame, however, remained constant at 22 %.Baxa and Cerner will continue to work together to aid Cerner clients in their evaluation and execution of Cerner-integrated DoseEdge. This original offering of Cerner-integrated DoseEdge is available just from Cerner. SOURCE Cerner Corporation.

Anxiety connected with poor asthma outcomes Anxiety sensitivity, in simple terms, is a concern with fear. But when people who have anxiety sensitivity have asthma also, their suffering could be far more debilitating and harmful, because they have difficulty managing their asthma. A new research explores this presssing issue and recommends treatment to greatly help decrease asthma symptoms.